AMA Endorses Cloning for Research
Posted on: Tuesday, 17 June 2003, 06:00 CDT
The American Medical Association on Tuesday endorsed cloning for research purposes, saying it is medically ethical but allowing doctors who oppose the practice to refuse to perform it.
Policymaking delegates adopted the measure without debate after discussing the issue Sunday.
"It makes a stance for science," said Dr. Michael Goldrich, incoming chairman of the committee that drafted the cloning report.
The proposal focused on a laboratory procedure designed to create embryos to cultivate their stem cells, which are master cells that can potentially grow into any type of human tissue. Scientists believe such cells could potentially be used to treat a wide range of human diseases.
Such early embryos would be discarded when they consist of only a few cells, but they could theoretically develop into a human if implanted into a woman's uterus.
The AMA's Council on Ethical and Judicial Affairs submitted the proposal with hopes that it would become official AMA policy.
The proposal received wide support from doctors and medical groups including the American Society for Reproductive Medicine. But some adamantly opposed it with arguments reminiscent of the nationwide abortion debate.
Calling embryo cloning for research purposes medically ethical is "totally inappropriate ... when a number of us believe that human beings start with two cells," said Dr. John McMahon of Helena, Mont.
The proposal echoed recommendations from a National Academy of Sciences panel last year, which advocated a government ban on cloning to produce humans but said cloning for research should be allowed.
The U.S. House earlier this year passed a Bush administration-backed measure that would ban both types of cloning. The measure hasn't been acted on in the Senate.
In other action Tuesday, the AMA agreed to investigate the ethics of letting drug company sales representatives sit in on patients' visits with their doctors.
Drug companies sometimes pay doctors up to $500 a day to allow their reps to observe patient visits - a practice they maintain is educational but which opponents say violates patients' privacy.
The AMA opposed the practice unless the patient has clearly consented without coercion and asked for guidelines to make sure patients are not coerced.
---
On the Net:
AMA: http://www.ama-assn.org
Related Articles
- Microsoft HealthVault and RelayHealth to Connect Doctors and Patients
- SearchBoth.Com; the First Search Engine for Doctors, Lawyers, Students, and Researchers
- Medicare Promotes the Value of One-on-One Time for Doctors and Patients
- Chairman of Patient Safety Technologies Named to Center for Patient Safety Research and Practice at the Brigham and Women's Hospital and Harvard Medical School
- Geron Announces Issuance of U.S. Patent for Production of Insulin Secreting Cells From Human Embryonic Stem Cells
- Geron Enters Into Research and Exclusive License Agreements With the University of Oxford for Derivation of Dendritic Cells From Human Embryonic Stem Cells
- Feature: China's Fifth Human Bird Flu Patient Receives First Checkup After Recovery
- A Normative Justification for Distinguishing the Ethics of Clinical Research
- Researchers Grow Stem Cells from Human Skin
- European Working Time Directive May Put Doctors' and Patients' Lives at Risk
 |
 |
User Comments (0)
RSS Feeds